Ignite Creation Date:
2025-12-24 @ 5:04 PM
Ignite Modification Date:
2026-01-28 @ 1:31 PM
Study NCT ID:
NCT03641950
Status:
COMPLETED
Last Update Posted:
2018-08-22
First Post:
2018-08-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Objective of This Study is to Evaluate the Efficacy and Safety of Botulax® in Patients With Essential Blepharospasm.
Sponsor:
Hugel
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
HG-BOT-IV3
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None